Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients

Mostrar otras versiones (1)

Omicron is currently the dominant SARS-CoV-2 variant and several sublineages have emerged. Questions remain about the impact of previous SARS-CoV-2 exposure on cross-variant immune responses elicited by BA.2 infection compared to BA.1. Here we show that without previous history of COVID-19, BA.2 inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hye Kyung, Knabl, Ludwig, Walter, Mary, Furth, Priscilla A., Hennighausen, Lothar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016656/
https://www.ncbi.nlm.nih.gov/pubmed/35441161
http://dx.doi.org/10.1101/2022.04.07.22273565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016656/
https://www.ncbi.nlm.nih.gov/pubmed/35441161
http://dx.doi.org/10.1101/2022.04.07.22273565

Ejemplares similares